Avalon Investment & Advisory Astrazeneca PLC Transaction History

Avalon Investment & Advisory

$3.56 Billion
Q1 2023

A detailed history of Avalon Investment & Advisory transactions in Astrazeneca PLC stock. As of the latest transaction made, Avalon Investment & Advisory holds 5,914 shares of AZN stock, worth $444,851. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,914

Previous 6,393 7.49%

Holding current value

$444,851

Previous $433,000 5.31%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $30,248 - $34,296	-479 Reduced 7.49%	5,914 $410,000
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $60,227 - $78,258	-1,111 Reduced 14.81%	6,393 $433,000
Q3 2022 Nov 01, 2022	SELL	$53.02 - $135.75 $24,018 - $61,494	-453 Reduced 5.69%	7,504 $412,000
Q2 2022 Aug 10, 2022	SELL	$59.26 - $71.14 $33,422 - $40,122	-564 Reduced 6.62%	7,957 $526,000
Q1 2022 May 17, 2022	SELL	$55.72 - $67.12 $437,123 - $526,556	-7,845 Reduced 47.93%	8,521 $565,000
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $771,405 - $911,492	-14,280 Reduced 46.6%	16,366 $953,000
Q3 2021 Nov 08, 2021	SELL	$55.56 - $60.79 $1.69 Million - $1.85 Million	-30,450 Reduced 49.84%	30,646 $1.84 Million
Q2 2021 Jul 29, 2021	SELL	$48.42 - $60.18 $187,675 - $233,257	-3,876 Reduced 5.97%	61,096 $3.66 Million
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $1.14 Million - $1.31 Million	-24,076 Reduced 27.04%	64,972 $3.23 Million
Q4 2020 Feb 08, 2021	SELL	$48.52 - $58.02 $52,061 - $62,255	-1,073 Reduced 1.19%	89,048 $4.45 Million
Q3 2020 Nov 04, 2020	SELL	$53.07 - $61.1 $107,254 - $123,483	-2,021 Reduced 2.19%	90,121 $4.94 Million
Q2 2020 Aug 07, 2020	SELL	$43.1 - $55.31 $933,632 - $1.2 Million	-21,662 Reduced 19.03%	92,142 $4.87 Million
Q1 2020 May 05, 2020	BUY	$37.79 - $51.33 $1.79 Million - $2.43 Million	47,338 Added 71.22%	113,804 $5.08 Million
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $327,451 - $389,147	-7,712 Reduced 10.4%	66,466 $3.31 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $102,426 - $116,084	-2,553 Reduced 3.33%	74,178 $3.31 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $286,086 - $319,852	7,674 Added 11.11%	76,731 $3.17 Million
Q1 2019 Apr 24, 2019	SELL	$35.49 - $43.02 $55,044 - $66,724	-1,551 Reduced 2.2%	69,057 $2.79 Million
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $470,075 - $529,121	-12,753 Reduced 15.3%	70,608 $2.68 Million
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $913,353 - $1.04 Million	26,276 Added 46.03%	83,361 $3.3 Million
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $56,178 - $60,243	-1,626 Reduced 2.77%	57,085 $2 Million
Q1 2018 Jun 26, 2018	BUY	$32.97 - $36.63 $252,187 - $280,182	7,649 Added 14.98%	58,711 $2.05 Million
Q1 2018 Jun 22, 2018	SELL	$32.97 - $36.63 $252,187 - $280,182	-7,649 Reduced 13.03%	51,062 $1.77 Million
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $252,187 - $280,182	7,649 Added 14.98%	58,711 $2.05 Million
Q4 2017 Jun 22, 2018	SELL	$32.09 - $34.78 $8,439 - $9,147	-263 Reduced 0.51%	51,062 $1.77 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $187,983 - $203,741	5,858 Added 12.88%	51,325 $1.78 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $256,556 - $301,206	8,859 Added 24.2%	45,467 $1.54 Million
Q2 2017 Aug 14, 2017	BUY	N/A	36,608	36,608 $1.25 Million

Others Institutions Holding AZN

# of Institutions

1,343

Shares Held

492M

Call Options Held

4.99M

Put Options Held

3.19M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Investment & Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Investment & Advisory with notifications on news.

Account

Avalon Investment & Advisory Astrazeneca PLC Transaction History